What does Atea Pharmaceuticals, Inc. do?
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in…
What is Atea Pharmaceuticals, Inc.'s P/E and P/B ratio?
Atea Pharmaceuticals, Inc. has a P/E ratio of -1.9 and a P/B ratio of 1.59.
What is Atea Pharmaceuticals, Inc.'s debt-to-equity ratio?
Atea Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.00.
How much does Atea Pharmaceuticals, Inc. owe compared with what it owns?
Atea Pharmaceuticals, Inc. owes $0.12 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Atea Pharmaceuticals, Inc.'s Positivity rank?
Atea Pharmaceuticals, Inc. is ranked #3,400 of 6,774 companies globally and #1,443 of 4,000 in United States on PositoAI, with a Positivity Score of 20,596.
Does Atea Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Atea Pharmaceuticals, Inc..
Where can I read the latest news about Atea Pharmaceuticals, Inc.?
Recent headlines about Atea Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Atea Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Atea Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.